Last update 27 Aug 2025

Pulmongene (Hong Kong) Co., Ltd.

Private Company|2019|Hong Kong SAR, Hong Kong

Overview

Basic Info

Introduction
Established in Hong Kong on March 19, 2019, Pulmongene Ltd. is a company dedicated to the innovation and development of novel pharmaceuticals targeting respiratory illnesses and organ fibrosis treatments.

Tags

Other Diseases
Respiratory Diseases
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Monoclonal antibody1
Top 5 TargetCount
AREG(amphiregulin)1

Related

1
Drugs associated with Pulmongene (Hong Kong) Co., Ltd.
PMG-1015
Target
AREG
Mechanism
AREG modulators [+1]
Active Org.
Pulmongene (Hong Kong) Co., Ltd.
Originator Org.
Pulmongene (Hong Kong) Co., Ltd.
Active Indication
Idiopathic Pulmonary Fibrosis
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
3
Clinical Trials associated with Pulmongene (Hong Kong) Co., Ltd.
NCT05895565
/ RecruitingPhase 1
A Phase 1b, Multicenter, Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PMG1015 in Idiopathic Pulmonary Fibrosis (IPF) Subjects
CTR20221571
/ CompletedPhase 1
评估PMG1015注射液在健康志愿者中的安全性、耐受性、药代动力学和免疫原性的、随机、双盲、安慰剂对照、单剂量递增的Ia期研究
[Translation] A randomized, double-blind, placebo-controlled, single-ascending dose Phase Ia study to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of PMG1015 injection in healthy volunteers
NCT05022771
/ CompletedPhase 1
A Phase 1A, First in Human, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of PMG1015 in Healthy Volunteers
100 Clinical Results associated with Pulmongene (Hong Kong) Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Pulmongene (Hong Kong) Co., Ltd.
Login to view more data
100 Deals associated with Pulmongene (Hong Kong) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Pulmongene (Hong Kong) Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 Aug 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
PMG-1015
 ( AREG )		Idiopathic Pulmonary Fibrosis
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free